Trial
NCT03679481
The Effect of Tranexamic Acid on Blood Loss and Transfusion Requirements Following Open Femur Fracture Surgery
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
The University of Texas Health Science Center, Houston
Collaborators
—
Condition
Blood Loss Following Open Femur Fracture Surgery
Intervention
Tranexamic acid (TXA)
Why stopped
study not started due to lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-17